Costs of Community-Based Viral Hepatitis Screening in Cameroon Using Point-of-Care Technologies

Nkengeh N Tazinkeng; Amir M Mohareb; Akwi W Asombang; Emily P Hyle

doi:10.1093/ofid/ofae378

Costs of Community-Based Viral Hepatitis Screening in Cameroon Using Point-of-Care Technologies

Open Forum Infect Dis. 2024 Jul 3;11(7):ofae378. doi: 10.1093/ofid/ofae378. eCollection 2024 Jul.

Authors

Nkengeh N Tazinkeng^{1

2

3}, Amir M Mohareb^{4

5

6}, Akwi W Asombang^{2

3

6}, Emily P Hyle^{4

5

6}

Affiliations

¹ Department of Population Health Research, Health Education and Research Organization, Buea, Cameroon.
² Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Department of Research, Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.
⁴ Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁵ Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁶ Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Abstract

This cost analysis of a community-based viral hepatitis screening program in Cameroon found an investment of $3.52 per person screened, $50.63 per new diagnosis of hepatitis B, $159.45 per new diagnosis of hepatitis C, and $47.97 per new diagnosis of either hepatitis B or C.

Keywords: Cameroon; costs; hepatitis B; hepatitis C; point-of-care.

Grants and funding

K01 AI166126/AI/NIAID NIH HHS/United States